Become a premium subscriber

Get unlimited access to Endpoints News by joining our community of premium subscribers. Directly support our mission to deliver the best news product in biopharma and become an essential read for industry leaders like you.

Endpoints Insider

Individual license that unlocks premium features

$400 per year

  • Premium Gated Content

    Covers you individually, unlocking all premium features

  • Reader Library Access

    View and download PDFs covering major industry highlights each year

  • Event Discounts

    Get priority access and special rates to Endpoints News events around the world

Upgrade to Insider
Endpoints Enterprise

Company-wide license that unlocks premium features

Custom pricing

  • Unlimited Company License

    Unlocks all premium gated content for every employee under your corporate domain

  • Reader Library Access

    View and download PDFs covering major industry highlights each year

  • Two Featured Job Posts

    A $1,800 value on Endpoints Careers

  • Corporate Intranet Access

    Use our news content in your corporate intranet and other internal uses

Request a quote

Now a part of the Financial Times family, our ambitions are stronger than ever to give you the essential news, information, and insights you need to stay ahead.